About Crucell (OTCMKTS:CRXLY)
Crucell NV is a Netherlands-based biopharmaceutical company. The Company is focused on developing, producing and marketing products that combat infectious diseases. The Company's product candidates include flu-mAb, an antibody product effective against a range of influenza virus strains, tuberculosis and malaria vaccines, as well as a rabies monoclonal antibody combination, all produced on its PER.C6 human cell-line technology. It focuses on the paediatric, travel and endemic, and respiratory fields. Its core product portfolio includes Quinvaxem, a liquid pentavalent vaccine against five important childhood diseases; Hepavax-Gene, a hepatitis B vaccine; Epaxal, an aluminum-free hepatitis A vaccine; Vivotif and Dukoral, oral vaccines against typhoid and cholera; and Inflexal V, a virosomal adjuvanted vaccine against influenza. It has offices in the Netherlands, China, Indonesia, Italy, Korea, Malaysia, Spain, Sweden, Switzerland, the United Kingdom, the United States and Vietnam.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Crucell (OTCMKTS:CRXLY) Frequently Asked Questions
What is Crucell's stock symbol?
Crucell trades on the OTCMKTS under the ticker symbol "CRXLY."
Who are some of Crucell's key competitors?
Some companies that are related to Crucell include Tencent (TCEHY), Nestlé (NSRGY), Roche (RHHBY), Electrolux (ELUXY), LVMH Moet Hennessy Louis Vuitton (LVMUY), L'Or�al (LRLCY), Siemens (SIEGY), Naspers (NPSNY), Allianz (AZSEY), Volkswagen Group (VLKAY), Bayer (BAYRY), BASF (BASFY), BNP Paribas (BNPQY), Bouygues (BOUYF), Nippon Telegraph and Telephone (NTTYY), Airbus Group (EADSY), Daimler (DDAIF) and SoftBank Group (SFTBY).
Has Crucell been receiving favorable news coverage?
News articles about CRXLY stock have been trending somewhat positive on Sunday, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Crucell earned a coverage optimism score of 0.22 on Accern's scale. They also assigned headlines about the biopharmaceutical company an impact score of 47.86 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future.
How do I buy shares of Crucell?
Shares of CRXLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Crucell?
Crucell's mailing address is Archimedesweg 4, LEIDEN, 2333CN, Netherlands. The biopharmaceutical company can be reached via phone at +31-71-5199100.
MarketBeat Community Rating for Crucell (CRXLY)MarketBeat's community ratings are surveys of what our community members think about Crucell and other stocks. Vote "Outperform" if you believe CRXLY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRXLY will underperform the S&P 500 over the long term. You may vote once every thirty days.
Crucell (OTCMKTS:CRXLY) Analyst Ratings History
(Data available from 4/22/2016 forward)
Crucell (OTCMKTS:CRXLY) Earnings History and Estimates Chart
Crucell (OTCMKTS CRXLY) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Crucell (OTCMKTS:CRXLY) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Crucell (OTCMKTS CRXLY) Insider Trading and Institutional Ownership History
Crucell (OTCMKTS CRXLY) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Crucell (OTCMKTS CRXLY) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Crucell (OTCMKTS:CRXLY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Crucell (OTCMKTS CRXLY) Stock Chart for Sunday, April, 22, 2018